ADVM-022 Gene Therapy for nAMD May Reduce Anti-VEGF Injection Burden
The single-injection investigative gene therapy may help with providing continuous expression of aflibercept.
Gene Therapy BIIB112 Promising for X-Linked Retinitis Pigmentosa
The AAV8 vector–based gene therapy was associated with improvements in 2 measures of visual function.
Imaging End Points a Good Indicator of Therapeutic Response in Retinitis Pigmentosa
Optical coherence tomography characteristics may be predictive of the efficacy of intravitreal injection of allogeneic human retinal progenitor cells, according to research presented at ARVO 2021.
